Home › NDC Lookup › RxCUI directory › RxCUI 1098143

24 HR niacin 750 MG Extended Release Oral Tablet — RxCUI 1098143

RxNorm drug concept · Semantic clinical drug
RxCUI 1098143 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 26 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1098143
Official name24 HR niacin 750 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known as24 HR vit-B3 750 MG Extended Release Oral Tablet; niacin 750 MG 24HR Extended Release Oral Tablet; 24 HR nicotinic acid 750 MG Extended Release Oral Tablet; 24 HR vitamin B3 750 MG Extended Release Oral Tablet
FDA products mapped8
Package NDCs mapped26
Reported Medicaid activity (SDUD)3,873 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Niacin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You're right that niacin is a B vitamin, but at prescription doses it works as a medicine to improve your blood fat levels. It can lower LDL (bad cholesterol) and triglycerides, an...
  • Why did my doctor prescribe niacin — isn't that just a vitamin?
  • That warmth, redness, and tingling — especially on your face and neck — is the most common side effect of niacin and is called flushing. It can feel alarming the first few times, b...
  • What's that hot, red, flushing feeling — is something wrong?
📖 Read our full Niacin guide →

🕸️ Concept Web — How 24 HR niacin 750 MG Extended Release Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR niacin 750 MG Extended Release Oral Tablet RxCUI 1098143

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Niacin 7393
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Niacin Extended Release Oral Tablet 205199
    • Niacin Oral Product 1158120
    • Niacin Pill 1158121
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Niacin 750 MG 316344

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Niacin 750 MG SCDC · 316344
  • Niacin Extended Release Oral Tablet SCDF · 205199
  • Niacin Oral Product SCDG · 1158120
  • Niacin Pill SCDG · 1158121

📦 FDA Products & Package NDCs

8 products · 26 package NDCs
26 package NDCs map to RxCUI 1098143 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
47335-0539-08 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0539-18 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (4733... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0539-81 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0539-83 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0539-88 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0613-08 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0613-18 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (4733... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0613-81 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0613-83 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0613-88 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0614-18 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (4733... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0614-81 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0614-83 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
47335-0614-88 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335... NIACIN Sun Pharmaceutical Industries, Inc. 2014-06-27
59651-0018-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-018-05) Niacin Aurobindo Pharma Limited 2018-02-01
59651-0018-18 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-018-18) Niacin Aurobindo Pharma Limited 2018-02-01
59651-0018-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-018-90) Niacin Aurobindo Pharma Limited 2018-02-01
59651-0019-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-019-05) Niacin Aurobindo Pharma Limited 2018-02-01
59651-0019-18 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-019-18) Niacin Aurobindo Pharma Limited 2018-02-01
59651-0019-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-019-90) Niacin Aurobindo Pharma Limited 2018-02-01
59651-0020-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-020-05) Niacin Aurobindo Pharma Limited 2018-02-01
59651-0020-18 180 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-020-18) Niacin Aurobindo Pharma Limited 2018-02-01
59651-0020-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-020-90) Niacin Aurobindo Pharma Limited 2018-02-01
65162-0322-03 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65162-... Niacin Amneal Pharmaceuticals LLC 2015-12-11
65162-0322-09 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65162-... Niacin Amneal Pharmaceuticals LLC 2015-12-11
65162-0322-50 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65162... Niacin Amneal Pharmaceuticals LLC 2015-12-11
Observed labelers: Sun Pharmaceutical Industries, Inc. (14) · Aurobindo Pharma Limited (9) · Amneal Pharmaceuticals LLC (3) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.